| Literature DB >> 31982341 |
Deepak Choudhury1, Aswathi Ashok2, May Win Naing2.
Abstract
Organoids have been successfully exploited for drug screening, disease modeling, pathogenesis, and regenerative medicine. Herein, we discuss the progress achieved in the commercialization of organoids in the last few years. We further elaborate on the concept of organoid biobank and highlight ethical and regulatory issues surrounding organoid research and commercialization.Keywords: commercialization; in vitro models; organoids; stem cells; tissue engineering
Mesh：
Year: 2020 PMID： 31982341 DOI： 10.1016/j.molmed.2019.12.002
Source DB: PubMed Journal: Trends Mol Med ISSN： 1471-4914 Impact factor: 11.951